This is what is interesting.....
They received millions
This is what is interesting.....
They received millions from their so called partners and here we are stuck in limbo at .05 and we have no clue what the heck is going on with anything other than Joe bashing other companies and the Board of Directors simply not doing anything at all.
People can claim investigations, can claim all kind of things, but the problem is we have no clue and all the while we know that Generex / NuGenerex did receive money to move ahead, they were supposed to submit to the FDA, it was supposed to go smoothly for NASDAQ, they had all these deals in place to make all kinds of profit and we know nothing about anything going on. All the while PPS dropped like a rock, shareholders dumped their stock to avoid further losses, Joe trashed other vaccines while remaining silent on his own companies which further did a lot of damage in confidence and the list goes on.
And here we are. Is it fair? Heck no, but here we are. Shareholders deserve a lot better than this in Generex and in NuGenerex. They were supposed to get it with Joe and for all his promises and his commitments, he has not delivered yet after everything. Bad choices and just some bad deals and honestly lack of confidence in my view. The science and the products are most certainly there, but the question is the leadership and right now, that is a huge question and based on the PPS, most don't believe in it at all. Joe needs to either prove to his 'hundres of thousands' of shareholders, he is the leader he said he is or get out of the way and let someone else more able to lead whomever that might be. But someone needs to put Generex and NuGenerex moving into the right direction. .05 just will not do it and NGIO sitting there waiting to get listed after several years will not do it either after being told it is the cleanest ever. I still believe there is values in all what both companies have. Leadership just needs to deliver in them both before again, it is to late and just talking about other vaccine makers won't do it.
Rant over.....
2
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...
Continue Reading
The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...
Continue Reading
Shining a Light on Essential Family Farmers Every year, thousands gather for Farm Aid to back the unsung heroes who put food on our plates. In 2026, the scene shifted to the amphitheater at Virginia Beach, where an epic lineup of music took stage not just to entertain but to underline a critical issue—family farmers are fighting for survival. These folks aren't merely...
Continue Reading
Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...
Continue Reading
Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....
Continue Reading
Taking Flight with Legacy and Tradition Throwing a bash on Times Square isn't just about flash; it's about letting folks know you mean business. And China Southern Airlines has been doing just that for 70 years. Imagine starting from Guangzhou and ending up splashed across New York City's giant LED screens—talk about a journey! From Humble Roots to Global Network...
Continue Reading
A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...
Continue Reading
PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...
Continue Reading
Modular Solutions Steal the Show in Bangkok When a company draws 59,468 attendees from over 150 countries, folks pay attention—and that was exactly the scene at Gastech 2026 in Bangkok. The name buzzing on many lips? Endurance Energy. These guys showcased a fresh take on energy logistics with their skid-mounted liquefaction tech, turning heads with their Southeast Asia...
Continue Reading
CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...
Continue Reading
Top 5 Most Recently Viewed Articles
West Harbor's Phase 2 Development Unveiled West Harbor, the incredible waterfront destination, is on the brink of major expansion as it accelerates its Phase 2 development. With plans to incorporate more than 125,000 square feet of new tenant leases, this project is set to transform the LA Waterfront into a vibrant hub for entertainment and dining experiences. New...
Continue Reading
CARVYKTI® got its moment in the sun after the CARTITUDE-4 study dropped some serious data on treating multiple myeloma back in 2024. This ain't just another therapy; it's the first cell treatment that showed it can really boost survival rates for patients who’ve been through the wringer—those dealing with relapsed or lenalidomide-refractory cases. Yeah, you heard...
Continue Reading
Holding Edwards Lifesciences Accountable In the context of the ongoing financial landscape, it's essential to stay informed, especially if you have investments in significant firms like Edwards Lifesciences Corporation (NYSE: EW). Investors who feel they have suffered losses due to any potential mismanagement by company executives should take active steps to understand...
Continue Reading
Recent Momentum in the Biotechnology Sector The biotechnology sector has been buzzing with activity, particularly in the realm of momentum stocks. Amidst strong technical indicators, four standout stocks have captured the attention of investors. These stocks are not only exhibiting positive price movement but are also entering elite percentile ranks for momentum gains....
Continue Reading
STMicroelectronics Expands Funding for Future Technologies STMicroelectronics NV (NYSE: STM) has recently secured a significant financing agreement with the European Investment Bank, aimed at enhancing research and development (R&D) initiatives, as well as expanding manufacturing capacity across Europe. Details of the Financing Agreement The European Investment Bank...
Continue Reading